COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,673 Articles (22,913 medRxiv, 8,760 bioRxiv)

Most recent first Previous |  Page 2903: Articles 29021-29030  | Next

Beyond the Spike: identification of viral targets of the antibody response to SARS-CoV-2 in COVID-19 patients
Hachim, A., Kavian, N., Cohen, C. A., Chin, A. W., Chu, D. K., Mok, C. K. P., Tsang, O. T., Yeung, Y. C., Perera, R. A., Poon, L. L., Peiris, M. J., Valkenburg, S. A.
10.1101/2020.04.30.20085670 — Posted: 2020-05-02 Discussion: Onsite
Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses
Mutnal, M. B., Arroliga, A. C., Walker, K., Mohammad, A. A., Brigmon, M. M., Beaver, R. M., Midturi, J. K., Rao, A.
10.1101/2020.04.30.20086116 — Posted: 2020-05-02 Discussion: Offsite
Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients
Norman, M., Gilboa, T., Ogata, A. F., Maley, A. M., Cohen, L., Cai, Y., Zhang, J., Feldman, J. E., Hauser, B. M., Caradonna, T. M., Chen, B., Schmidt, A. G., Alter, G., Charles, R. C., Ryan, E. T., Walt, D. R.
10.1101/2020.04.28.20083691 — Posted: 2020-05-02
Early viral clearance and antibody kinetics of COVID-19 among asymptomatic carriers
Zhang, Z., Xiao, T., Wang, Y., Yuan, J., Ye, H., Wei, L., Wang, H., Liao, X., Qian, S., Wang, Z., Liu, L.
10.1101/2020.04.28.20083139 — Posted: 2020-05-02 Discussion: Onsite | Offsite
Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19)
Radon, K., Saathoff, E., Pritsch, M., Guggenbuehl Noller, J. M., Kroidl, I., Olbrich, L., Thiel, V., Diefenbach, M., Riess, F., Forster, F., Theis, F. J., Wieser, A., Hoelscher, M., KoCo19 collaboration group
10.1101/2020.04.28.20082743 — Posted: 2020-05-02 Discussion: Offsite
Inflammatory markers in Covid-19 Patients: a systematic review and meta-analysis.
Vaseghi, G., Mansourian, M., Karimi, R., Heshmat-Ghahdarijani, k., Rouhi, P., Shariati, M., Haghjoo Javanmard, S.
10.1101/2020.04.29.20084863 — Posted: 2020-05-02
Reduced COVID-19-Related Critical Illness and Death, and High Risk of Epidemic Resurgence, After Physical Distancing in Ontario, Canada
Tuite, A., Greer, A. L., De Keninck, S., Fisman, D. N.
10.1101/2020.04.29.20084475 — Posted: 2020-05-02
How should hospitals manage the backlog of patients awaiting surgery following the COVID-19 pandemic? A demand modelling simulation case study for carotid endarterectomy
Martin, G., Clarke, J., Markar, S., Carter, A. W., Mason, S., Purkayastha, S., Darzi, A., Kinross, J., Collaborative, P.
10.1101/2020.04.29.20085183 — Posted: 2020-05-02
CovidCounties - an interactive, real-time tracker of the COVID-19 pandemic at the level of US counties
Arneson, D., Elliott, M., Mosenia, A., Oskotsky, B., Vashisht, R., Zack, T., Bleicher, P., Butte, A. J., Rudrapatna, V. A.
10.1101/2020.04.28.20083279 — Posted: 2020-05-02
Coding variants in ACE2 and TMPRSS2 are not major drivers of COVID-19 severity in UK Biobank subjects.
Curtis, D.
10.1101/2020.05.01.20085860 — Posted: 2020-05-02 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).